Notes

Promoting Wellness Collateral Through Data-Driven Decision-Making: A neighborhood Health Section Reaction to COVID-19.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long non-coding RNA MNX1-AS1 promotes migration and invasion of esophageal squamous cell carcinoma by upregulating IGF2, by D.-N. Zheng, C.-J. Zhang, G.-P. Sun, published in Eur Rev Med Pharmacol Sci 2019; 23 (14) 6179-6185-DOI 10.26355/eurrev_201907_18431-PMID 31364117" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/18431.Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long noncoding RNA SNHG7 represses the expression of RBM5 to strengthen metastasis of hepatocellular carcinoma, by B.-Z. Sun, D.-G. Ji, Z.-X. Feng, Y. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (13) 5699-5704-DOI 10.26355/eurrev_201907_18307-PMID 31298322" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/18307.Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3, by H.-P. Liu, Y. Zhang, Z.-T. Liu, H. Qi, X.-M. Zheng, L.-H. Qi, J.-Y. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (21) 9286-9294-DOI 10.26355/eurrev_201911_19421-PMID 31773696" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/19421.The article "MiR-182-5p inhibited proliferation and migration of ovarian cancer cells by targeting BNIP3, by X.-N. Jia, S.-D. Yin, Y. Wei, L. Chen, published in Eur Rev Med Pharmacol Sci 2019; 23 (8) 3270-3276-DOI 10.26355/eurrev_201904_17688-PMID 31081079" has been withdrawn from the authors. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/17688.Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells, by J.-Y. Zhang, Y.-N. Li, X. Mu, Z.-L. Pan, W.-B. Liu, published in Eur Rev Med Pharmacol Sci 2018; 22 (24) 8599-8608-DOI 10.26355/eurrev_201812_16623-PMID 30575899" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/16623.The article "Effects of long non-coding RNA URHC on proliferation, apoptosis and invasion of colorectal cancer cells, by Z.-G. Gu, G.-H. PI3K/AKT-IN-1 research buy Shen, J.-H. Lang, W.-X. Huang, Z.-H. Qian, J. Qiu, published in Eur Rev Med Pharmacol Sci 2018; 22 (6) 1658-1664-DOI 10.26355/eurrev_201803_14577-PMID 29630109" has been withdrawn from the authors. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/14577.Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "The role of miR-99b in mediating hepatocellular carcinoma invasion and migration, by C.-J. Liu, J.-H. Yang, F.-Z. Huang, J.-H. Yang, C.-P. Liu, X.-H. Mao, W.-M. Yi, X.-B. Shen, C. Peng, M.-F. Chen, B. Jiang, J.-S. Wu, published in Eur Rev Med Pharmacol Sci 2018; 22 (8) 2273-2281-DOI 10.26355/eurrev_201804_14815-PMID 29762829" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https//www.europeanreview.org/article/14815.In recent years, robot-assisted thoracic surgery is gaining more and widespread interest in Europe. Due to the narrow space and the complexity of anatomical structures, conventional minimally invasive mediastinal surgery may be challenging for the thoracic surgeon. Robot-assisted mediastinal surgery opens up new possibilities for minimally invasive surgery, as it permits greater dexterity, a three-dimensional view, and tremor adjustment, which allows the surgeon to perform complex procedures in small thoracic spaces. As robotic platforms continue to evolve, more complex mediastinal thoracic surgical interventions will be facilitated, translating to improved outcomes for patients. This article provides an overview of the current status of robot-assisted mediastinal surgery and summarises general aspects of the indication, set-up and steps of robot-assisted thoracoscopic surgery in mediastinal mass resections.Sepsis and acute respiratory distress syndrome (ARDS) constitute devastating conditions with high morbidity and mortality. Sepsis results from abnormal host immune response, with evidence for both pro- and anti-inflammatory activation present from the earliest phases. The "proinflammatory" response predominates initially causing host injury, with later-phase sepsis characterized by immune cell hypofunction and opportunistic superinfection. ARDS is characterized by inflammation and disruption of the alveolar-capillary membrane leading to injury and lung dysfunction. Sepsis is the most common cause of ARDS. Approximately 20% of deaths worldwide in 2017 were due to sepsis, while ARDS occurs in over 10% of all intensive care unit patients and results in a mortality of 30 to 45%. Given the fact that sepsis and ARDS share some-but not all-underlying pathophysiologic injury mechanisms, the lack of specific therapies, and their frequent coexistence in the critically ill, it makes sense to consider therapies for both conditions together. In this article, we will focus on the therapeutic potential of mesenchymal stem/stromal cells (MSCs). MSCs are available from several tissues, including bone marrow, umbilical cord, and adipose tissue. Allogeneic administration is feasible, an important advantage for acute conditions like sepsis or ARDS. They possess diverse mechanisms of action of relevance to sepsis and ARDS, including direct and indirect antibacterial actions, potent effects on the innate and adaptive response, and pro-reparative effects. MSCs can be preactivated thereby potentiating their effects, while the use of their extracellular vesicles can avoid whole cell administration. While early-phase clinical trials suggest safety, considerable challenges exist in moving forward to phase III efficacy studies, and to implementation as a therapy should they prove effective.
Homepage: https://www.selleckchem.com/products/pi3k-akt-in-1.html